We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
251
TSMC
TSM
$2.18T
$1.28M 0.07%
22,620
+7,580
+50% +$399K
KR icon
252
CALL
Kroger
KR
$34.8B
$1.28M 0.07%
+37,800
New +$1.23M
ROCK icon
253
Gibraltar Industries
ROCK
$1.49B
$1.28M 0.07%
26,654
+1,305
+5% +$58K
YELP icon
254
Yelp
YELP
$1.41B
$1.28M 0.07%
55,350
+52,113
+1,610% +$1.14M
LOW icon
255
Lowe's Companies
LOW
$125B
$1.27M 0.07%
+9,380
New +$1.07M
UAA icon
256
Under Armour
UAA
$2.6B
$1.26M 0.07%
+129,454
New +$1.23M
LSCC icon
257
Lattice Semiconductor
LSCC
$18.5B
$1.26M 0.07%
44,369
+38,911
+713% +$909K
INTU icon
258
Intuit
INTU
$89B
$1.25M 0.07%
+4,238
New +$1.16M
ALXN
259
DELISTED
Alexion Pharmaceuticals
ALXN
$1.25M 0.07%
11,174
+10,848
+3,328% +$1.15M
MAT icon
260
Mattel
MAT
$4.23B
$1.25M 0.07%
+129,433
New +$1.18M
REGN icon
261
PUT
Regeneron Pharmaceuticals
REGN
$80.8B
$1.25M 0.07%
+2,000
New +$1.14M
MU icon
262
Micron Technology
MU
$991B
$1.25M 0.07%
24,191
-184,671
-88% -$8.71M
ADBE icon
263
CALL
Adobe
ADBE
$105B
$1.22M 0.07%
+2,800
New +$1.04M
AKAM icon
264
Akamai
AKAM
$15.9B
$1.21M 0.07%
11,311
+5,410
+92% +$544K
AA icon
265
Alcoa
AA
$13.2B
$1.21M 0.07%
107,665
+16,636
+18% +$149K
VRSK icon
266
Verisk Analytics
VRSK
$25B
$1.21M 0.07%
7,101
+1,011
+17% +$160K
CRWD icon
267
CrowdStrike
CRWD
$218B
$1.2M 0.07%
47,976
+34,376
+253% +$689K
SLB icon
268
PUT
SLB Ltd
SLB
$75B
$1.2M 0.07%
65,000
META icon
269
CALL
Meta Platforms (Facebook)
META
$1.51T
$1.18M 0.07%
5,200
+3,500
+206% +$731K
NUV icon
270
Nuveen Municipal Value Fund
NUV
$1.91B
$1.18M 0.06%
115,590
-41,815
-27% -$410K
TIF
271
PUT
DELISTED
Tiffany & Co.
TIF
$1.17M 0.06%
9,600
+3,300
+52% +$413K
BMY.RT
272
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.17M 0.06%
326,943
+180,427
+123% +$651K
VRTX icon
273
CALL
Vertex Pharmaceuticals
VRTX
$126B
$1.16M 0.06%
+4,000
New +$1.08M
TAST
274
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.16M 0.06%
239,214
+13,773
+6% +$52K
ZEN
275
DELISTED
ZENDESK INC
ZEN
$1.15M 0.06%
+12,984
New +$1,000K

Similar funds

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.